Terms And Conditions
  1. Home
  2. Terms And Conditions
SDI Limited (ASX: SDI): Improved earnings qua...
By ACE Investors / 22 Jun 2026
Read More
Cochlear Limited (ASX: COH): Focus on achievi...
By ACE Investors / 19 Jun 2026
Read More
Pediatrix Medical Group Inc. (NYSE: MD): Pric...
By ACE Investors / 18 Jun 2026
Read More
Cogent Biosciences Inc (NASDAQ: COGT): Buildi...
By ACE Investors / 17 Jun 2026
Read More
Nuvalent, Inc (NASDAQ: NUVL): Advancing a por...
By ACE Investors / 15 Jun 2026
Read More
Abbott Laboratories (NYSE: ABT): Becomes one ...
By ACE Investors / 15 Jun 2026
Read More
Imricor Medical Systems, Inc. (ASX: IMR): Sig...
By ACE Investors / 12 Jun 2026
Read More
Pro Medicus Limited (ASX: PME): Expanded its ...
By ACE Investors / 10 Jun 2026
Read More
Compumedics Limited (ASX: CMP): Materially ex...
By ACE Investors / 01 Jun 2026
Read More
Jazz Pharmaceuticals Plc. (NASDAQ: JAZZ): Mat...
By ACE Investors / 28 May 2026
Read More
Sonic Healthcare Limited (ASX: SHL): Reinforc...
By ACE Investors / 27 May 2026
Read More
Enovis Corporation (NYSE: ENOV): Focused on s...
By ACE Investors / 27 May 2026
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2025 ACE Investors. All Right Reserved. Design by Ace Investors